WNT2B, Wnt family member 2B, 7482

N. diseases: 65; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.010 AlteredExpression disease BEFREE However, an increased co-localization of E-CADHERIN and VIMENTIN, an increased number of cells expressing WNT2b and a higher expression of FZD4 and WNT2b/FZD4 interaction were detected in intestinal tissue from the penetrating compared with the stenotic CD behavior. 31359032 2020
CUI: C0000768
Disease: Congenital Abnormality
Congenital Abnormality
0.010 AlteredExpression group BEFREE Expression Analysis of ACSL5 and Wnt2B in Human Congenital Pulmonary Airway Malformations. 30463708 2018
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.010 Biomarker disease BEFREE miR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT2B mediated Wnt/β-catenin pathway in non-small cell lung cancer. 30015869 2018
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 Biomarker disease BEFREE Wnt2B co-operates with Frizzled7 to mediate MET in colorectal cancer. 28560804 2018
CUI: C0017638
Disease: Glioma
Glioma
0.010 AlteredExpression disease BEFREE Furthermore, based on data from the R2: Genomics Analysis and Visualization Platform, the expression of Wnt2b and 5a, and frizzled 2, 6 and 7 were highly associated with the prognosis of patients with glioma. 29387236 2018
CUI: C0029463
Disease: Osteosarcoma
Osteosarcoma
0.010 AlteredExpression disease BEFREE Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway. 29108989 2018
CUI: C0267556
Disease: Osmotic diarrhea
Osmotic diarrhea
0.010 GeneticVariation disease BEFREE Homozygous nonsense mutations in WNT2B were identified in three individuals from two unrelated families with severe, neonatal-onset osmotic diarrhea after whole-exome sequencing was performed on trios from the two families. 29909964 2018
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.010 AlteredExpression disease BEFREE Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway. 29108989 2018
CUI: C1332986
Disease: Childhood Osteosarcoma
Childhood Osteosarcoma
0.010 AlteredExpression disease BEFREE Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway. 29108989 2018
Malignant neoplasm of colon and/or rectum
0.010 Biomarker disease BEFREE Wnt2B co-operates with Frizzled7 to mediate MET in colorectal cancer. 28560804 2018
CUI: C0023895
Disease: Liver diseases
Liver diseases
0.010 Biomarker group BEFREE These findings provided new insights into the pathophysiology of liver fibrosis by characterizing Wnt2b as a novel endogenous suppressor of TLR4 signaling, maintaining tissue homeostasis during the early stage of hepatic fibrosis-associated liver diseases. 28638086 2017
CUI: C0025202
Disease: melanoma
melanoma
0.010 GeneticVariation disease BEFREE By performing functional prediction and stepwise selection, we identified two independent SNPs (i.e., WNT2B rs1175649 G>T and BTRC rs61873997 G>A) that showed a predictive role in CM-specific survival, with an effect-allele-attributed hazards ratio (adjusted hazards ratio) of 1.99 (95% confidence interval = 1.41-2.81, P = 8.10 × 10<sup>-5</sup>) and 0.61 (0.46-0.80, 3.12×10<sup>-4</sup>), respectively. 28499756 2017
CUI: C0151779
Disease: Cutaneous Melanoma
Cutaneous Melanoma
0.010 GeneticVariation disease BEFREE By performing functional prediction and stepwise selection, we identified two independent SNPs (i.e., WNT2B rs1175649 G>T and BTRC rs61873997 G>A) that showed a predictive role in CM-specific survival, with an effect-allele-attributed hazards ratio (adjusted hazards ratio) of 1.99 (95% confidence interval = 1.41-2.81, P = 8.10 × 10<sup>-5</sup>) and 0.61 (0.46-0.80, 3.12×10<sup>-4</sup>), respectively. 28499756 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.010 Biomarker disease BEFREE These findings provided new insights into the pathophysiology of liver fibrosis by characterizing Wnt2b as a novel endogenous suppressor of TLR4 signaling, maintaining tissue homeostasis during the early stage of hepatic fibrosis-associated liver diseases. 28638086 2017
CUI: C0027794
Disease: Neural Tube Defects
Neural Tube Defects
0.010 AlteredExpression group BEFREE The results demonstrated that the transcriptional activities of Wnt2b and Wnt7b were abnormally upregulated in mouse fetuses with NTDs and, in the GC‑rich promoters of these genes, histone 3 lysine 4 (H3K4) acetylation was enriched, whereas H3K27 trimethylation was reduced. 26548512 2016
CUI: C0027092
Disease: Myopia
Myopia
0.010 AlteredExpression disease BEFREE The amounts of Wnt2b, Fzd5 and β-catenin mRNA and protein were significantly greater in form-deprived myopia eyes than in control eyes.DKK-1 (antagonist) reduced the myopic shift in refractive error and increase in axial elongation, whereas Norrin had the opposite effect in FDM eyes. 24755605 2014
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 Biomarker group BEFREE Using normal mucosa, the association of ACSL5 and Wnt2B was seen, but in intestinal neoplasias the mechanism was only rudimentarily observed. 25356045 2014
CUI: C0034951
Disease: Refractive Errors
Refractive Errors
0.010 AlteredExpression group BEFREE The amounts of Wnt2b, Fzd5 and β-catenin mRNA and protein were significantly greater in form-deprived myopia eyes than in control eyes.DKK-1 (antagonist) reduced the myopic shift in refractive error and increase in axial elongation, whereas Norrin had the opposite effect in FDM eyes. 24755605 2014
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
0.010 AlteredExpression group BEFREE Here we show that secretion of WNT2B and WNT9B and stabilization of β-catenin (CTNNB1) upon virus infection negatively regulate expression of representative inducible genes IFNB1, IFIT1 and TNF in a CTNNB1-dependent effector mechanism. 23785285 2013
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.010 Biomarker disease BEFREE These data suggest that Wnt2B indeed plays an important role in ovarian cancer metastasis and drug resistance. 22635028 2012
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial
0.010 Biomarker disease BEFREE These data suggest that Wnt2B indeed plays an important role in ovarian cancer metastasis and drug resistance. 22635028 2012
CUI: C2607914
Disease: Allergic rhinitis (disorder)
Allergic rhinitis (disorder)
0.010 Biomarker disease BEFREE A total of 39 single nucleotide polymorphisms (SNPs) distributed over the genes PIP, WNT2B, CLC and PLUNC were selected from dbSNP, genotyped and investigated for associations with allergic rhinitis. 19650845 2010
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.010 AlteredExpression disease BEFREE Reverse transcription polymerase chain reaction (RT-PCR) analysis of B-cell progenitor acute lymphoblastic leukaemia (ALL) cells revealed expression of Wnt genes, including WNT2B in 33%, WNT5A in 42%, WNT10B in 58% and WNT16B in 25% of cases. 17614820 2007
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.010 Biomarker group LHGDN Anti-WNT2B monoclonal antibodies, WNT2B RNAi compounds, or small molecule WNT2B inhibitors could be developed as novel therapeutic agents for gastric cancer and esophageal cancer in the field of clinical oncology. 16273293 2005
CUI: C0038356
Disease: Stomach Neoplasms
Stomach Neoplasms
0.010 Biomarker group LHGDN WNT2B: comparative integromics and clinical applications (Review). 16273293 2005